Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 mars 2020 07h00 HE | Source: Arcellx, Inc.

Arcellx Announces FDA Orphan Drug Designation for CART-ddBCMA for the Treatment of Multiple Myeloma

GAITHERSBURG, Md., March 12, 2020 (GLOBE NEWSWIRE) -- Arcellx, a clinical-stage biopharmaceutical company devoted to developing immune cell therapies for cancer and other diseases, today announced...
28 févr. 2020 07h00 HE | Source: Arcellx, Inc.

Arcellx Announces First Patient Treated with T Cell Therapy Utilizing the Company’s Novel Binding Domain

– Phase 1 trial is designed to validate novel binding domain; first step in evaluating Arcellx T cell therapy platform in the clinic – – Future trials will use Arcellx platform to direct T cell...
03 oct. 2019 07h00 HE | Source: Arcellx, Inc.

Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform

GAITHERSBURG, Md., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Arcellx, a privately-held biopharmaceutical company, today announced that it has raised $85 million in an oversubscribed Series B financing....